奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期大肠癌36例临床分析

来源 :肿瘤研究与临床 | 被引量 : 0次 | 上传用户:ooo2005net
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的研究奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期大肠癌的疗效及毒副作用。方法奥沙利铂130 mg/m2,静脉滴注,第1天,亚叶酸钙100 mg/m2,氟尿嘧啶500 mg静脉推注后,350 mg/m2静脉滴注,第1天~第5天。21 d 1周期,至少3个周期。结果36例CR8.3 %,PR38.9 %,SD38.9 %,PD13.9 %,总有效率(RR):47.2 %(17/36)。结论奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期大肠癌的疗效肯定,毒副作用也能耐受。 Objective To study the efficacy and side effects of oxaliplatin plus leucovorin and fluorouracil in the treatment of advanced colorectal cancer. Methods Oxaliplatin 130 mg / m2, intravenous infusion, on the first day, leucovorin 100 mg / m2, fluorouracil 500 mg intravenous infusion, 350 mg / m2 intravenous drip, the first day to the fifth day. 21 d 1 cycle, at least 3 cycles. Results 36 cases of CR8.3%, PR38.9%, SD38.9%, PD13.9%, total effective rate (RR): 47.2% (17/36). Conclusion Oxaliplatin in combination with leucovorin and fluorouracil is effective in treating advanced colorectal cancer with tolerable side effects.
其他文献